October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Prostate cancer is the most common cancer in men, with an estimated one in eight Canadian men expected to be diagnosed in ...

During Movember, Michaela Hagenhofer, general manager, commercial operations at Johnson & Johnson Innovative Medicine, ...

According to the 2019 National Cancer Registry the lifetime risk for prostate cancer in South Africa is 1 in every 15 man. Prostate cancer is the most common cancer in men globally and is showing a ...

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

I once thought that prostate cancer should be the center of my universe, but with everything else going on, now I’m not so ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...